Brief: Cogent Biosciences Presents Preclinical Data Highlighting Precision Oncology Pipeline On Molecular Targets And Cancer Therapeutics
14/10/2023 17:40
Oct 14 (Reuters) - Cogent Biosciences Inc COGT.O :
* COGENT BIOSCIENCES PRESENTS PRECLINICAL DATA HIGHLIGHTING
PRECISION ONCOLOGY PIPELINE AT THE 2023 AACR-NCI-EORTC
INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER
THERAPEUTICS
* COGENT BIOSCIENCES INC SAYS IND AND INITIATION OF CLINICAL
TRIAL
PLANNED IN 2H 2024
Source text for Eikon: ID:nGNX6MBYjQ
Further company coverage: COGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cogent Biosciences
See all newsBrief: Cogent Biosciences - Enters Commercial Supply Agreement With Hovione On Sept 1, 2026 - SEC Filing
Brief: Cogent Biosciences - May Offer Up To $400 Million In Common Stock Through Guggenheim Securities
Cogent Biosciences Q2 net loss widens on higher expenses
Brief: Cogent Biosciences Q2 Net Income USD -96.405 Million
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's